These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26747370)

  • 21. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
    Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
    Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
    Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
    Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
    Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study.
    Müller CP; Carey RJ; Salloum JB; Huston JP
    Neuropharmacology; 2003 Apr; 44(5):592-603. PubMed ID: 12668045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
    Renoir T; Païzanis E; El Yacoubi M; Saurini F; Hanoun N; Melfort M; Lesch KP; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1149-62. PubMed ID: 18611291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M; Kennett GA; Curzon G
    Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release.
    Kidd EJ; Garratt JC; Marsden CA
    Eur J Pharmacol; 1991 Jul; 200(1):131-9. PubMed ID: 1837523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
    Szabo ST; Blier P
    Synapse; 2001 Dec; 42(4):203-12. PubMed ID: 11746719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
    Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
    Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
    Gobbi G; Bambico FR; Mangieri R; Bortolato M; Campolongo P; Solinas M; Cassano T; Morgese MG; Debonnel G; Duranti A; Tontini A; Tarzia G; Mor M; Trezza V; Goldberg SR; Cuomo V; Piomelli D
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18620-5. PubMed ID: 16352709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
    Su SH; Wu YF; Lin Q; Hai J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.
    Coomber B; O'Donoghue MF; Mason R
    Synapse; 2008 Oct; 62(10):746-55. PubMed ID: 18651640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.